UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.)

 

 

Filed by the Registrant  ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material under §240.14a-12

AADI BIOSCIENCE, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

 

No fee required.

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 


                                  
                        
   

 

Your Vote Counts!

          

        

 

 

 

AADI BIOSCIENCE, INC.

 

2022 Annual Meeting of Stockholders

Vote by June 13, 2022

11:59 PM ET

          
   
 

     LOGO     

   

AADI BIOSCIENCE, INC.

 

17383 SUNSET BOULEVARD, SUITE A250

 

PACIFIC PALISADES, CA 90272

 

        
   

    

    

    

   
 
 
              
 
     

D81756-P74631

                                       
            
           

 

Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on June 14, 2022.

You invested in AADI BIOSCIENCE, INC. and it’s time to vote!

You have the right to vote on proposals being presented at the Annual Meeting.

Get informed before you vote

View the Notice, Proxy Statement and 2021 Annual Report online at www.ProxyVote.com OR you can receive a free paper or email copy of the material(s) by requesting prior to May 31, 2022. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 (toll-free from the U.S., U.S. territories and Canada) or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

 

 

LOGO

 

 

    *Please check the meeting materials for any special requirements for meeting attendance.

V1.1


Vote at www.ProxyVote.com

 

 

 

THIS IS NOT A VOTABLE BALLOT

 

This is an overview of the proposals being presented at the upcoming Stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

  

 

 

  Voting Items   Board
Recommends
 

1.

   To elect two Class II directors to serve on the Company’s board of directors until the Company’s 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified, or until their earlier resignation, death or removal:  
 
   Nominees:  
 
   01) Anupam Dalal, M.D.   LOGO  For
    

02) Karin Hehenberger, M.D., Ph.D.

 

   
 

2.

  

To ratify the appointment of BDO USA LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

 

  LOGO  For

NOTE: Such other business as may properly come before the meeting or any adjournment thereof.

 

   

    

    

 
 

    

 

 

 

Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.

 

D81757-P74631

Aerpio Pharmaceuticals (NASDAQ:ARPO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Aerpio Pharmaceuticals Charts.
Aerpio Pharmaceuticals (NASDAQ:ARPO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Aerpio Pharmaceuticals Charts.